Introduction
Though liver transplantation has long been recognized as the definitive therapy for end stage liver disease (ESLD), its full potential remains elusive due to a severe shortage of donor organs. In the US, there were 7335 liver transplants in 2016 , but 12 305 patients were waitlisted and 2873 died or were removed from the list without receiving a graft during the same period (1) . While expansion of the donor pool is paramount, the equitable distribution of existing organ supplies is a prime concern for transplant professionals and their parent federal administrative body, the Organ Procurement and Transplantation Network (OPTN) (2) (3) (4) . Current policy development efforts have shown the inadequacy of traditional measures of assessing need in liver transplantation, however, and have underscored the necessity for deeper understanding of geographic disparities in risk and access among ESLD patients (5) .
Proposed changes in liver organ distribution policy have sought to minimize differences in access by more broadly sharing donated livers from regions with higher donation rates to those with greater perceived demand, as measured by the number of patients awaiting transplant. The basis for shifting organ distribution is the difference in transplant candidates' Model for End Stage Liver Disease (MELD) scores at the time of transplant between OPTN regions, as well as greater waiting times for patients in certain areas (4) . These arguments expose a paradox, however, as regions identified as having "excess" organs also have waitlist mortality rates nearly twofold higher than those with fewer donors (6) . Despite extensive discussion, the causes of this excess mortality remain obscure, as do the implications of reduced organ availability in higher-mortality regions. Complicating this assessment are the inherent differences health and healthcare access in geographically separated areas with distinct demographic characteristics.
In this paper, we set out to assess the degree to which sociodemographic considerations alter waitlisted candidates' prognosis. While previous work has failed to show a consistent effect of race or ethnicity on waitlist outcome (7, 8) , low socioeconomic status has been linked to inferior survival and reduced access to high-quality centers (9) . Patients from rural areas have reduced waitlist access, and excess distance between candidates' place of residence and nearest transplant center has similarly been shown to lower transplant rates and decrease waitlist survival (10, 11) . These risk factors, when taken in combination, likely influence the lethality of liver disease and shape mortality while awaiting transplant. We hypothesized that liver transplant candidates' survival potential is dictated in part by local resources and conditions, as measured by a previously-validated index of multiple county-level health indicators (12, 13) , as well as distance to their transplant center. In studying the scope and distribution of these risk factors, we also sought to understand the potential impact of current federal redistribution proposals among at-risk communities throughout the nation.
Materials and Methods

Data sources and study population
Approval for data collection and analysis was obtained through the Emory University Institutional Review Board. Data were obtained from the Scientific Registry of Transplant Recipients (SRTR). The SRTR data system includes data on all donor, waitlisted candidates, and transplant recipients in the US, submitted by the members of the Organ Procurement and Transplantation Network (OPTN), and has been described elsewhere. The Health Resources and Services Administration (HRSA), U.S. Department of Health and Human Services provides oversight to the activities of the OPTN and SRTR contractors. Patients were eligible for inclusion if they were waitlisted for a liver transplant between January 1, 2002, and December 31, 2014 (n = 141 381). Patients were excluded if they were missing demographic or MELD data (n = 10 801), if they had no permanent ZIP (n = 12 704), if their ZIP of residence could not be resolved to a single county (n = 2114) or if their county of residence did not have a calculated Community Health Score (n = 1415). Corroborative data on community risk indicators were gathered from the 2010 United States Census, the Census Small Area Health Insurance Estimate, and the American Association of Family Practitioners (AAFP) Robert Graham Center (14) . County-level records of ESLD deaths over the study period were obtained from the Centers for Disease Control and Prevention, using individual ICD-10 codes (15).
Study variables
The primary outcomes of the study were liver transplant waitlist mortality, defined as death on the waiting list due to any cause, and posttransplant mortality. Waitlist mortality was defined as removal from the waitlist due to medical unsuitability, death, or deterioration until too ill for transplant (16) . Mortality at any point was defined as having a valid OPTN-derived death date.
The primary exposure in the study was the cumulative Community Health Score (CHS), a previously described composite indicator of proxy variables for community health, environmental and behavioral risks, social conditions, and access to care (12) . This index is produced in collaboration between the University of Wisconsin Population Health Institute and the Robert Wood Johnson Foundation, and collates data from the National Center for Health Statistics, the Behavioral Risk Factor Surveillance System, the National Center for Chronic Disease Prevention and Health Promotion, the Dartmouth Institute, and the U.S. Census (17 
Statistical analysis
Demographic and clinical characteristics of the study population were examined using Chi-square and t-tests. A multivariable Cox proportional hazards model was fitted to assess association between CHS (in groups) and mortality on the waitlist, adjusting for clinical and demographic factors. Patients were censored at time of death, transplant, or the end of follow-up (December 1, 2014). Robust sandwich variance estimators were used to account for potential correlation within OPTN regions. To assess waitlist mortality in the setting of competing risks in the form of transplantation, the method of Fine and Gray was used (18) . Secondary analyses using multivariable Cox proportional hazards models estimated associations between CHS and mortality posttransplant and mortality at any point after waitlisting (not censored at transplantation). To evaluate potential differences in the benefit of transplantation by CHS, we dichotomized CHS above and below 30, and included an interaction term with receipt of a transplant in the model of mortality at any time after listing. A two-sided alpha of 0.05 was used to assess statistical significance. In order to study the potential effects of changes to distribution policy on at-risk populations, we employed publicly available data from the United Network for Organ Sharing Liver Simulated Allocation Model (LSAM) program. These data reflect projected changes to the annual transplant volume within administrative units known as Donor Service Areas (DSAs) under the "Eight District Model" of the Redesigning Liver Distribution proposal (19) . All analyses were conducted in SAS 9.3.1 (Cary, NC).
Results
Study population
A total of 114 347 patients met inclusion criteria for the study. The median CHS score for the study population was 19.4 (standard deviation: 10.1). Patients were categorized by CHS quartiles as shown in Table 1 . While age at transplant was consistent across CHS groupings, African American race showed stepwise variation with CHS (5.4% vs. 14.6% between lowest and highest CHS quartiles, p < 0.001). Hispanic ethnicity was less common in high-CHS than low-CHS quartiles (11.7% vs. 7.1%, p < 0.001). Highest level of educational achievement correlated inversely with higher CHS, with candidates in the lowest CHS group 50% more likely to have at least some college attendance than those in the highest-CHS tier (45.4% vs. 30.3%, p < 0.001). High-CHS patients were more heavily concentrated in OPTN Regions 2, 3, 10, and 11. There were no significant differences in MELD at listing across CHS quartiles. Patients in higher-CHS quartiles were more likely to live farther from their Table 3 shows the results of multivariable Cox and competing risks analyses of mortality on the transplant waitlist. Increasing age and MELD score at listing were associated with increased waitlist mortality, as was ESLD due to hepatitis C virus (HCV Kaplan-Meier analysis was performed to assess the impact of CHS on waitlist survival while awaiting transplant. As shown in Figure 1 , higher CHS was associated with lower survival (p < 0.001 between CHS 1-10 and 31-40). support. Survival varied with region, with lowest risk in Regions 5 and 6, and highest in Region 9. CHS was significant with regard to posttransplant mortality in univariate analysis, but did was not significant in the full model. Similarly, extended travel distance was not associated with a consistently significant effect in the multivariable model.
Waitlist mortality
Receipt of a liver transplant
The effect of transplantation on waitlist mortality as related to CHS was studied using an interaction model. In this analysis, there was no difference in the rate of death after listing (HR for low-CHS/transplantation 0.415, 95% CI 0.378-0.456, HR for high-CHS/transplantation 0.418, 95% CI 0.387-0.452, p = 0.64).
Regional distribution of sociodemographic risk and excess travel distance
The proportion of liver transplant candidates in counties with a CHS of 31-40 ranged from 0% (multiple states) to 87.7% (Mississippi). In total, 14 states had no candidates in the highest quartile CHS, and another 10 states had less than 5% of their waitlist composed of high-CHS candidates. In contrast, 8 states had more than 50% of their liver transplant waitlist patients residing in counties with a CHS of 31-40. Census data showed strong concordance between both the general population and waitlist at the DSA level with regard to proportion residing in high-CHS counties (R 2 = 0.991). Figure 2A depicts the proportion of waitlisted individuals in each DSA residing Figure 3A displays the proportion of waitlisted patients living >100 miles from their listing center across DSAs, with expected change in transplant volume shown in Figure 3B . While excess travel distance and high CHS affect DSAs to differing degrees, these risk factors are predominantly present in regions projected to lose transplant volume. Figure 4 illustrates changes to DSA volume based on both CHS and travel distance. Under the eight-district model, DSAs with >25% of candidates living either more than 100 miles from their transplant centers or in counties with a CHS of 31-40 would lose a total of 260 livers per year, while DSAs with fewer patients in these categories would gain 287 livers per year.
Discussion
We applied a composite scale-the CHS scoreencapsulating local conditions including environmental hazards, prevalence of comorbid conditions, behavioral attributes, and quality of healthcare, to the national liver transplant waitlist to examine how changes in liver distribution policy might impact patients living in areas with lower sociodemographic characteristics. Our hypothesis was that sociodemographic disparities exert influence on waitlist mortality at multiple levels, from reduced social support and personal resources to infrequent or inferior health maintenance and delayed or inadequate response to clinical decompensation. In our analysis, we found that counties with higher CHS scores have a higher proportion of rural, poor, and black individuals. Findings among waitlist patients were similar, showing candidates in high-risk counties more likely to be of black race, have public insurance, and live farther from their listing transplant center. The proportion listed with an intrinsic MELD above 30 was lower, possibly reflecting increased lethality of mid-range MELD scores, or lower referral rates or successful completion of waitlist requirements for more ill patients from vulnerable areas. Among the general population in these counties, the death rate from ESLD is almost twice that of counties in the lowest tier of CHS, and fewer candidates are listed for each person dying from liver disease in these areas. With regard to waitlist patients, we compared mortality rates using both Cox and competing risks multivariable analysis. Though mostly consistent, the competing risks model did show effects possibly reflecting different likelihood of transplant across OPTN regions. Most notably, HCC was associated with high mortality risk in the Cox model, but was protective in competing risks analysis. This is likely due to the disproportionately poor prognosis among cancer patients not transplanted, and the higher likelihood of waitlist survival for HCC patients with low intrinsic MELD scores. Similarly, the beneficial effect on waitlist survival was increased in regions with relatively higher rates of transplantation. In the case of CHS, the change in effect between Cox and competing risks models underscores the importance of transplantation to the prognosis of candidates in high-risk counties. Even when adjusting for regional organ availability, patients at excess sociodemographic risk fare disproportionately worse in a model that does not treat transplant as a competing risk.
In both models, excess travel distance to the listing center increased mortality risk. Posttransplant survival and transplant benefit were unaffected by high sociodemographic risk and travel distance. The distribution of high-risk communities is not uniform throughout the United States, and the majority of these communities are in areas that already have high waitlist mortality and stand to lose organs under existing redistribution proposals. The implications of these findings are that patients in disadvantaged counties are exposed to mortality risks that are partially offset by the competing risk of relatively good access to transplant organs. Current organ redistribution strategies, which are based primarily on the Prior work on sociodemographic elements of liver transplant candidacy has emphasized placement on the waitlist, rather than progression to transplantation, as the crux of patient access. In particular, multiple studies have shown minority patients with ESLD and liver cancer are less likely to be waitlisted (8, 20, 21) . Other studies have shown patients with lower socioeconomic status are more likely to receive inferior care for HCC and have delayed waitlist access (22, 23) . Because of selection effects among patients completing the evaluation and listing process for transplant, however, the magnitude of racial and sociodemographic disparities is more difficult to discern, and MELD-based allocation has been accepted as intrinsically fair in part because of its strict biological basis (24, 25) . Indeed, within the liver-transplant community, the main topic of discussion with regard to disparity is that of large-scale geography. Variability in regional listing practices has led to a wide range in perceived prevalence of liver disease nationwide (26) . Differences in organ donation rates and the frequency of granting MELD exceptions to boost likelihood of transplant further confound objective estimates of true regional supply and demand (27, 28) . With regard to federal law, however, the requirement to avoid geographic disparities is subordinate to the mandate that allocation "shall be designed. . . to promote patient access to transplantation" (29) . The results of our study suggest that not only is there a need to address community-level disparities, but that large-scale changes under consideration will worsen inequities and exacerbate mortality for already disadvantaged patients.
Our study has standard limitations of data quality and completeness associated with retrospective reviews of registry data. In addition, the main exposure variable is a community-level, rather than individual-level, variable, since individual level estimates are not available in national registry data. Sociodemographic conditions impart different effects on individuals within the same group, and direct correlations cannot be ascribed to community data without potential for ascertainment bias or ecological fallacy. Despite these limitations, consideration of local conditions has the potential to add substantially to risk assessment. The higher prevalence of comorbid conditions, reduced access to care, environmental exposures, and behavioral attitudes characterizing high-risk counties likely modify the biological course of ESLD in ways that otherwise go unmeasured (30) . While individual effects from minority race, low socioeconomic status, and rural or remote location may not rise to the level of clinical or statistical significance, community conditions representing the summation of these risks may identify individuals underserved by current practices. The manner in which these conditions increase mortality risk is likely the product of many small missed opportunities in personal health maintenance and clinical management, rather than a single predominant event or limitation, but further study at a level beyond registry data is necessary to parse these out. A further limitation is that excess travel may select for individuals who are less representative of their remote location, as they have passed the capacity and resource barriers necessary to be successfully listed. Finally, the projections of transplant volume are based on LSAM modeling that cannot fully forecast behavioral changes with regard to patient and donor selection after any new liver distribution policy.
In summary, we found that sociodemographic risk, as measured by a composite community-level index, is associated with higher rates of ESLD death. Among waitlisted individuals, excess travel distance to the listing center worsened waitlist mortality. Residence in high-sociodemographic risk counties was associated with excess death while waitlisted, though increased transplant rates partially mask this risk. Individuals residing in high-risk communities and at greater distance from their center had equivalent postoperative survival to those in lower-risk areas, and derived equivalent benefit from the transplant. Donor service areas with high proportions of at-risk candidates, as measured by travel distance and community CHS, are projected to lose nearly 300 organs per year under current redistribution proposals. These findings suggest the need to further characterize individual and community level risks for ESLD patients in order to target interventions for reduction of waitlist mortality. Other possible approaches to minimizing disparities in waitlist mortality could include MELD exceptions or allocation and distribution protocols aiding underserved populations. National-level strategies for organ distribution must be sensitive to the relative prevalence of liver disease in communities and the variation in waitlist mortality associated with community effects, and should not compound risk to disadvantaged patients by reducing organ availability.
